ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,028Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 559

$372K Total Retail Price of All Prescriptions

Rank: 75 out of 559

423 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 338 298 1 3
LEVOTHYROXINE SODIUM 287 235 2 2
LISINOPRIL 257 220 3 1
OMEPRAZOLE 228 188 4 4
METFORMIN HCL 208 184 5 5
METFORMIN HCL ER 184 170 6 75
HYDROCODONE-ACETAMINOPHEN 181 92 S3 7 7
AMLODIPINE BESYLATE 181 170 7 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 131 9 18
ZOLPIDEM TARTRATE 168 98 10 17
ATENOLOL 159 131 11 15
GABAPENTIN 153 53 12 9
HYDROCHLOROTHIAZIDE 131 129 13 8
FLUOXETINE HCL 111 49 14 37
TRAZODONE HCL 109 46 15 28
JANUVIA 109 106 15 50
TAMSULOSIN HCL 98 92 17 25
MORPHINE SULFATE ER 97 54 S2 18 63
GLIPIZIDE ER 87 74 19 77
CITALOPRAM HBR 86 64 20 21
TRAMADOL HCL 83 57 21 27
LOVASTATIN 82 70 22 10
TERAZOSIN HCL 80 80 23 82
LOSARTAN-HYDROCHLOROTHIAZIDE 78 77 24 52
LOSARTAN POTASSIUM 74 74 25 14
FUROSEMIDE 74 68 25 11
ALENDRONATE SODIUM 73 71 27 13
CRESTOR 68 56 28 33
PANTOPRAZOLE SODIUM 65 53 29 41
WARFARIN SODIUM 64 58 30 24
AMITRIPTYLINE HCL 63 47 R 31 58
CYCLOBENZAPRINE HCL 63 15 R 31 54
TRIAMTERENE-HCTZ 60 41 33 47
OXYCODONE HCL 59 32 S2 34 32
LYRICA 59 36 34 125
OXYCODONE HCL-ACETAMINOPHEN 58 15 S2 36 70
GLIMEPIRIDE 54 49 37 53
ATORVASTATIN CALCIUM 54 49 37 20
PEN NEEDLE 54 36 37 150
METOPROLOL SUCCINATE 51 51 40 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.